ReviewTherapeutic advances in rare disease

Patient leadership and partnerships accelerate therapies for SCN8A and other developmental and epileptic encephalopathies.

Gabrielle Conecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.